Aerie pharmaceuticals, inc. announces the appointment of interim executive chair and departure of chairman and ceo

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company, today announced that it is executing its succession plan for its long-serving chairman and ceo and that effective september 17, 2021, vicente anido, phd. no longer serves as the company's chairman and chief executive officer or as a director of the company. consistent with the succession plan in place, the company's board of directors has appointed benjamin f. mcgraw, iii, pharm.d. a
AERI Ratings Summary
AERI Quant Ranking